Monthly Archives: October 2021
Acinar cell enriched–microRNA-802 connects the dots between Kras signaling, acinar ductal metaplasia and pancreatic cancer
AGA Institute and CAP Quality Measure Development for Detection of MMR Deficiency and Lynch Syndrome Management
Reply to Li J et al and Sun L et al.
Correction
Gebert J, Gelincik O, Oezcan-Wahlbrink M, et al. Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model. Gastroenterology 2021;161:1288–1302. Continue reading
Pathology Reporting of Esophagus Endoscopic Resections: Recommendations from the International Collaboration on Cancer Reporting
POST-ENDOSCOPY ESOPHAGEAL NEOPLASIA IN BARRETT’S ESOPHAGUS: CONSENSUS STATEMENTS FROM AN INTERNATIONAL EXPERT PANEL
An antigenically diverse, representative panel of envelope glycoproteins for HCV vaccine development
Development of a prophylactic hepatitis C virus (HCV) vaccine will require accurate and reproducible measurement of neutralizing breadth of vaccine-induced antibodies. Currently available HCV panels may not adequately represent the genetic and antigeni… Continue reading
Changes in metabolic syndrome status are associated with altered risk of pancreatic cancer: A nationwide cohort study
Metabolic syndrome (MetS) is reversible; however, the effect of changes in MetS status on pancreatic cancer risk is unknown. We aimed to investigate the effects of changes and persistence in MetS status on pancreatic cancer risk. Continue reading